Ferrlecit is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Sodium Ferric Gluconate Complex.
| Product ID | 0024-2792_17761b93-038d-494e-b6bb-7e1698db3d64 |
| NDC | 0024-2792 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ferrlecit |
| Generic Name | Sodium Ferric Gluconate Complex |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2011-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020955 |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | SODIUM FERRIC GLUCONATE COMPLEX |
| Active Ingredient Strength | 13 mg/mL |
| Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2011-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020955 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-03-01 |
| Ingredient | Strength |
|---|---|
| SODIUM FERRIC GLUCONATE COMPLEX | 12.5 mg/mL |
| SPL SET ID: | 1fe028ff-42ac-4329-b1a5-a9dadfcb79f6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0024-2792 | Ferrlecit | sodium ferric gluconate complex |
| 0024-2794 | Ferrlecit | sodium ferric gluconate complex |
| 0591-0149 | Sodium Ferric Gluconate Complex | Sodium Ferric Gluconate Complex |
| 0591-2508 | Sodium Ferric Gluconate Complex in Sucrose | Sodium Ferric Gluconate Complex |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FERRLECIT 75047697 2408958 Live/Registered |
A. NATTERMANN & CIE. GmbH 1996-01-24 |